Rafiq Hasan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Exonate Ltd : Exonate Appoints Dr Rafiq Hasan as Non-Executive Director

Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens Board Exonate Ltd., a biotechnology company developing novel

Rafiq hasanKatie odgaardZyme communicationsExonate ltdComplement therapeuticsSenior vice presidentGlobal headClinical evaluationNew eyedropAlleviating retinopathyDiabetic macular oedemaNon executive directorIhr portfolio

Exonate Ltd : CORRECTING and REPLACING Exonate Appoints Dr Rafiq Hasan as Non-Executive Director

EXONATE APPOINTS DR RAFIQ HASAN AS NON-EXECUTIVE DIRECTOR Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens

Rafiq hasanKatie odgaardZyme communicationsExonate ltdComplement therapeuticsSenior vice presidentGlobal headAlleviating retinopathyDiabetic eyeNon executive directorIhr portfolio

University spinout secures £63m to tackle diseases including main cause of blindness

CTx was spun out of the University of Manchester in 2021

United kingdomUnited statesSimon clarkRichard unwinRafiq hasanPaul bishopUniversity of manchesterUnited states complement therapeutics incA manchester universityUniversity of manchester innovation factoryManchester universityTherapeutics gmbhManchester innovation factoryComplement therapeuticsComplement therapeutics incComplement precision medicine

Complement Therapeutics raises €72m to combat leading cause of blindness

Complement Therapeutics raises €72m to combat leading cause of blindness
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesPaul bishopRichard unwinSimon clarkRafiq hasanUniversity of manchesterRegulatory agencyUniversity of manchester innovation factoryUnited states complement therapeutics incUnited kingdom complement therapeutics ltdComplement therapeutics gmbhComplement therapeutics ltdComplement therapeutics incComplement precision medicineProf simon clark

Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases

/PRNewswire/ Complement Therapeutics GmbH (CTx), a preclinical stage biotechnology company developing novel therapeutics for complement mediated diseases,.

United kingdomUnited statesDmitrij hristodorovRafiq hasanRoger franklin hadeanRob woodmanUnited states complement therapeutics incUnited kingdom complement therapeutics ltdRegulatory agencyUniversity of manchesterSeroba life sciencesHadean venturesSeroba lifeGeograpic atrophyComplement precision medicineInnovation passport